Phio Pharmaceuticals has received notice that its share price has fallen below Nasdaq’s $1 minimum bid-price requirement for 30 consecutive business days. The notice does not immediately affect the company’s Nasdaq listing or trading, and Phio has until May 17, 2027, to regain compliance.
- Phio can meet the requirement if its closing bid price is at least $1 per share for 10 consecutive business days before the deadline.
- The company says it will monitor its share price and evaluate options for regaining compliance. It did not specify what actions it may take.
- The notice starts a 180-day compliance period; it does not mean Phio’s stock is being delisted now.
